This was compared to the Ki‐67+ IHC manual count (versus QuPath Ki‐67+ tumour‐cell count) of 0.60% (vs. 0.60%), 0.68% (vs. 0.59%) for the low‐grade cMCTs and 69.43% (vs. 24.96%) for the high‐grade cMCT. The gene discussed is MKI67; the disease is neoplasm.